Abstract
Introduction: Acetylcholinesterase enzyme (AChE) is the main target in Alzheimer's disease therapy and designing of novel AChE inhibitors is a great deal of attention.
Methods: In this study, 2D-QSAR and 3D-QSAR models were generated using stepwise multiple linear regressions (SW-MLR) and comparative molecular field analysis (CoMFA) respectively.
Results: It was found that CoMFA model with r2 of 0.947 for the training set and r2 of 0.816 for the test set is more favorable than model which is established by SW-MLR method with r2 =0.825 and r2pred =0.778 in 2D-QSAR.
Conclusion: In addition, obtaining models were validated by cross validation with cut off values of q2 > 0.5 and r2pred > 0.6.
Keywords: Acetylcholinesterase, SW-MLR, CoMFA, QSAR, Enzyme, Piperazine.
Graphical Abstract
Current Computer-Aided Drug Design
Title:2D & 3D-QSAR Study on Novel Piperidine and Piperazine Derivatives as Acetylcholinesterase Enzyme Inhibitors
Volume: 14 Issue: 4
Author(s): Maryam Nazari, Sayyed Abbas Tabatabai and Elham Rezaee*
Affiliation:
- Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran,Iran
Keywords: Acetylcholinesterase, SW-MLR, CoMFA, QSAR, Enzyme, Piperazine.
Abstract: Introduction: Acetylcholinesterase enzyme (AChE) is the main target in Alzheimer's disease therapy and designing of novel AChE inhibitors is a great deal of attention.
Methods: In this study, 2D-QSAR and 3D-QSAR models were generated using stepwise multiple linear regressions (SW-MLR) and comparative molecular field analysis (CoMFA) respectively.
Results: It was found that CoMFA model with r2 of 0.947 for the training set and r2 of 0.816 for the test set is more favorable than model which is established by SW-MLR method with r2 =0.825 and r2pred =0.778 in 2D-QSAR.
Conclusion: In addition, obtaining models were validated by cross validation with cut off values of q2 > 0.5 and r2pred > 0.6.
Export Options
About this article
Cite this article as:
Nazari Maryam , Tabatabai Abbas Sayyed and Rezaee Elham *, 2D & 3D-QSAR Study on Novel Piperidine and Piperazine Derivatives as Acetylcholinesterase Enzyme Inhibitors, Current Computer-Aided Drug Design 2018; 14 (4) . https://dx.doi.org/10.2174/1573409914666180726092800
DOI https://dx.doi.org/10.2174/1573409914666180726092800 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Economic Translation of Paradigm-Changing Innovation: A Short History of Biotechnology
Technology Transfer and Entrepreneurship (Discontinued) Meet Our Editorial Board Member
Mini-Reviews in Medicinal Chemistry A Review on Metal Nanoparticles from Medicinal Plants: Synthesis, Characterization and Applications
Nanoscience & Nanotechnology-Asia Neurosteroids and Hepatic Encephalopathy: An Update on Possible Pathophysiologic Mechanisms
Current Molecular Pharmacology Synthesis, Chemistry and Utilities of Diaminoazoles with Special Reference to 3,5-diaminopyrazoles
Current Organic Synthesis WISP1 Neuroprotection Requires FoxO3a Post-Translational Modulation with Autoregulatory Control of SIRT1
Current Neurovascular Research Early Risk Factors for Nonadherence in Pediatric Type 1 Diabetes: A Review of the Recent Literature
Current Diabetes Reviews Suicidality and Cannabidiol: Opportunities and Challenges
Current Neuropharmacology Relapse Prevention
Adolescent Psychiatry Juvenile Delinquency and Challenges of Child and Adolescent Mental Health and Juvenile Justice in Japan
Adolescent Psychiatry Correlation between Systemic Lupus Erythematosus Activity and Plasma Levels of Monomeric Prolactin and Macroprolactin
Endocrine, Metabolic & Immune Disorders - Drug Targets New Molecular Avenues in Parkinson ’ s Disease Therapy
Current Topics in Medicinal Chemistry Therapeutic and Mechanistic Effects of Curcumin in Huntington’s Disease
Current Neuropharmacology Relevance of Mutations in Tau for Understanding the Tauopathies
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update
Current Pharmaceutical Design Recent Progress in Metal-Mediated Trifluoroethylation
Current Organic Chemistry Inulin as a Delivery Vehicle for Targeting Colon-Specific Cancer
Current Drug Delivery The Anterior-posterior Functional Connectivity Disconnection in the Elderly with Subjective Memory Impairment and Amnestic Mild Cognitive Impairment
Current Alzheimer Research Fetal Alcohol Syndrome: A Cautionary Note
Current Pharmaceutical Design Regulation of Neurogenesis and Angiogenesis in Depression
Current Neurovascular Research